




Since their commercial introduction in 1996, genetically modified (GM) crops
have been rapidly adopted in the United States. Because the Food and Drug
Administration (FDA) considers them “substantially equivalent” to their
traditional counterparts, GM crops require no special labeling and are managed
as commodities with no segregation or identity preservation. This is not the
case in other parts of the world where products containing genetically modified
ingredients must be labeled if their content exceeds specified threshold levels.
This dichotomy creates challenges for the food industry in complying with
various labeling guidelines in the countries in which they conduct business.
Compliance with such guidelines requires the availability of identity-
preservation systems and robust, accurate, specific, reliable, standardized, and
validated testing methods to ensure compliance with established threshold
levels for GM ingredients. Some food companies have indicated that they will
avoid the use of some or all GM ingredients in their products, although the
majority have not followed suit. Various consumer-interest groups are calling
for labeling of all products containing GM ingredients. The implications of such
labeling will be discussed. The food industry has been monitoring the opinions
of their consumers on the GM issue for the past several years, and the results of
these surveys will be shared.
ACCEPTANCE OF GM
Genetically modified crops are ubiquitous in the United States. In 2001, it is
predicted that 26% of the corn, 68% of the soybeans, and 69% of the cotton
grown in this country will be GM varieties. They have gone through rigorous
food- and environmental-safety tests; the FDA has reviewed fifty-nine GM
crops. Numerous scientific organizations and United States and international
regulatory agencies have endorsed their safety.
Examples of GM crops include insect-resistant (Bt) corn, cotton, potato, and
tomato; herbicide-tolerant soybean, corn, rice, sugar beet, flax and canola; and
virus-resistant squash, papaya, and potato. Advantages of insect- and virus-
resistant crops include improved yields and reduced use of pesticides.
Advantages of herbicide-tolerant crops include improved weed control, reduced
crop injury, use of short-lived herbicide, reduction in foreign matter, reduced
fuel use, and significant reduction in soil erosion. For these reasons, GM has
become the most rapidly adopted technology in the history of agriculture.
Genetically modified crops are managed as commodities in the United States,
and thus have made their way through commodity-distribution channels into
thousands of ingredients used in processed foods. Examples of soy-derived
ingredients include oil, lecithin, protein isolates, and mono- and diglycerides.
Examples of corn-derived ingredients include oil, starch, flour, meal, dextrose,
and high-fructose syrup. It has been estimated that 70 to 85% of processed
foods contain one or more ingredients potentially derived from GM crops.
Acceptance of GM products varies throughout the world, creating a challenge
for multinational food companies that have made commitments to take into
account consumer preferences when making decisions regarding the ingredients
in their products. Many countries have or are developing mandatory GM-
labeling guidelines. Retailers in the United Kingdom have banned the use of
GM ingredients in their private label products, causing major food companies
to respond in kind. GM-labeling guidelines differ throughout the world,
creating a complex situation for food manufacturers.
LABELING OF GM FOODS
Most food manufacturers are avoiding the use of GM ingredients in those
countries that have instituted mandatory GM-labeling, because consumers
perceive a label as a warning. To avoid such labeling requires the use of
ingredients derived from non-GM varieties that have been identity-preserved
throughout the entire supply chain: from seed to final product. Identity-
preservation (IP) systems add cost and complexity to the supply chain, and are
reliant upon adequate chain-of-custody documentation and GM-testing
systems. Unfortunately, there are few good estimates on the cost of IP
ingredients, but they may range from 5% to 150% over farm-gate prices. Food
manufacturers must develop new specifications for non-GM ingredients, and
audit systems to ensure compliance by ingredient suppliers. Manufacturers
must understand the complete profile of all primary and secondary ingredients
used in their products. For example, cornstarch is frequently used as a carrier
of vitamins in fortified products, but may not be identified as an ingredient in
the vitamin mix.
Mandatory labeling also demands the availability of robust standardized and
validated sampling and GM-testing systems that are quantitative, reliable,
accurate, and reproducible. Adventitious contamination due to cross-
pollination is inevitable; therefore, quantitative assays will be required for
setting tolerances or threshold levels of contamination. Tests must be simple,
inexpensive, and capable of detecting GM contamination in the range of
products in the marketplace. Unfortunately, validated and standardized
sampling and testing methods do not exist, except for a protein test for
Roundup Ready® soybean. Authenticated reference standards are not available,
and testing protocols vary from laboratory to laboratory. False-positive and
false-negative rates are unacceptably high. There is no standardization on how
the results are reported to food companies. The food matrix has a dramatic
impact on extractability of DNA and protein, and protocols will need to be
developed to take this into account. Since labeling is not required in the United
States, detection methods have not developed as rapidly has as GM technology.
This deficiency will cause significant issues as disputes arise about GM status of
foods.
Most food companies have decided to remove GM ingredients from products
marketed in countries with mandatory GM-labeling laws. Some companies are
sourcing raw agricultural commodities from countries (e.g. Brazil) that have not
yet approved the commercial cultivation of GM crops. However, this does not
provide adequate assurance of non-GM status, since it has been estimated that
13% (some estimates are as high as 25%) of Brazil’s 7.5 million acres of soybean
are planted to GM varieties, even though their use is not approved in that
country. Some companies (e.g. Gerber and Heinz) have decided to remove GM
ingredients from baby foods marketed in the United States. Frito Lay has
instructed its farmers not to grow GM corn varieties, and McDonald’s will avoid
GM potatoes. Neither Frito-Lay nor McDonald’s has said that it will avoid other
GM ingredients in its products, or that it will advertise or label its products as
non-GM.
The FDA recently published draft guidance on the voluntary labeling of
foods containing or not containing GM ingredients. In this document, the FDA
affirmed that mandatory labeling is not required for bioengineered food, unless
the food is “materially different.” Since the majority of bioengineered foods
reviewed by the FDA are substantially equivalent, no labeling is required in the
United States. For manufacturers who wish to voluntarily label their products,
the agency provides the following guidance: labels must be truthful and non-
misleading, therefore, data are required to substantiate label claims. The FDA
provided advice on terminology; “genetically modified” is not recommended
since it is not technically accurate; all food has been genetically modified
through conventional plant breeding. “Genetically modified organisms” is also
misleading as most foods do not contain viable organisms. The FDA believes
that it would be misleading to label a food as “GM-free” due to the potential for
adventitious contamination due to cross-pollination. They did not establish a
threshold level of contamination because accurate and reliable testing methods
do not exist. A statement that a food is not bioengineered nor does it contain
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bioengineered ingredients may be misleading if it implies the food is superior
to foods that are not so labeled. Further, to make a “non-bioengineered” claim,
all ingredients in the product must be from non-GM varieties, and if no
bioengineered varieties of that category of foods or ingredients are marketed,
such a claim would be misleading. Some companies are overtly labeling their
products as GMO-free or non-GM. They procure ingredients from suppliers
who certify that non-GM varieties have been used for ingredient manufacture.
However, a recent study by the Wall Street Journal reported that, of twenty
products labeled “non-GM,” sixteen contained measurable quantities of GM
DNA. Therefore, even under best-case scenarios, it is very difficult to guarantee
that the “non-GM” label is truthful.
“ORGANIC” AND OTHER CONCERNS
Organic growers have expressed concern that cross-pollinating GM crops such
as corn can jeopardize their crops. The USDA Organic Guidelines preclude
the use of genetic modification for anything to be labeled as organic. Since it
is impossible to prevent cross-pollination, it may be necessary to establish a
tolerance or threshold level for adventitious contamination.
Genetically modified foods do not appear to be as big a consumer issue in
the United States as in other parts of the world. Food manufacturers have been
monitoring their 800 numbers for an indication of how their consumers feel
about GM foods. To date, the number of calls on biotechnology remains very
small (0.1% to 0.2%) for most major food companies in this country. Awareness
has increased slightly over the past 18 months, and consumers are evenly
divided between support and opposition. Calls increase during periods of
intense media coverage. Companies targeted by activist groups report periodic
increases in numbers of calls. If a brief explanation of biotechnology is
provided, acceptance increases significantly, indicating that education is an
important factor in consumer acceptance.
Most food companies in the United States are not avoiding bioengineered
ingredients for domestic production. In general, the food-processing industry
has confidence in the safety of bioengineered foods. Because GM crops have
been readily adopted in the United States, availability of non-GM crops has
been limited and these ingredients are more expensive. Even when efforts are
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has confidence in the safety of bioengineered foods.
made to procure non-GM ingredients, adventitious contamination is an issue,
and IP systems have not been perfected as was illustrated with the StarLink™
incident in 2000. The food industry would need to be able to accurately
forecast their supply needs for non-GM ingredients so farmers could be
instructed on the quantities required. In addition, the food industry lacks
separate storage, processing, labeling and transportation capabilities required
to ensure separation of GM and non-GM raw materials and final products.
There is little confidence in the adequacy of current GM sampling and testing
methodology to substantiate label claims and there is substantial liability if
label claims are inaccurate. Finally, the food industry hopes that the next
generation of bioengineered products will deliver compelling consumer
benefits.
The food industry hopes that the next generation
of bioengineered products will deliver compelling
consumer benefits.
FUTURE OF AG AND FOOD BIOTECH
The next generation of bioengineered foods will focus on “output traits”
that provide processing advantages and tangible consumer-relevant benefits.
Biotechnology can be used to remove allergens, natural toxicants and
antinutritional factors from foods like peanuts, soybeans, rice, and wheat.
Taste, texture, aroma, ripening time and shelf life of fresh fruits and vegetables
can be improved. It will be possible to improve the nutritional quality of foods.
Examples include modification of the saturation level of oils to produce
products high in mono-unsaturated fatty acids that are more stable, resist
oxidation, do not require hydrogenation and reduce cholesterol levels when
consumed. It is possible to increase the content of vitamin E and other
antioxidants, and to insert the capability of producing plant-based omega-3
fatty acids into oil seeds. Biotechnology can be used to elevate levels of vitamins
A, C, and D, and folate, and enhance iron bioavailability in vegetables, fruits
and grains. It is also possible to increase levels of various phytochemicals in
plants that have been associated with disease prevention, e.g. lycopene in
tomatoes and sulfurofane in broccoli for reducing cancer risk, and lutein in
vegetables for reducing risk of macular degeneration. The advancing fields of
human and plant genomics and proteomics will identify additional plant-based
compounds that could have positive effects on human health. These are the
kinds of products that excite food companies and ultimately will excite
consumers.
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The future of agricultural and food biotechnology will depend on a number
of factors including continued grower support, food-industry and retailer
unanimity on policies regarding the use of GM ingredients, government
consistency, documentation of tangible consumer benefits without undue risk,
and consumer education and acceptance. Additionally, until there is interna-
tional harmonization on GM foods, turmoil in the marketplace will continue.
Without consumer acceptance and a coordinated approach across all segments
of the food-supply chain, the promises of agricultural and food biotechnology
could be limited.
The advancing fields of human and plant genomics and
proteomics will identify additional plant-based compounds
that could have positive effects on human health. These
are the kinds of products that excite food companies and
ultimately will excite consumers.
